ClariVest Asset Management LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 4.2% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 70,212 shares of the healthcare conglomerate’s stock after selling 3,106 shares during the period. UnitedHealth Group comprises about 1.6% of ClariVest Asset Management LLC’s holdings, making the stock its 10th largest position. ClariVest Asset Management LLC’s holdings in UnitedHealth Group were worth $36,063,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in UnitedHealth Group by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 80,630,913 shares of the healthcare conglomerate’s stock valued at $41,119,347,000 after purchasing an additional 1,147,051 shares in the last quarter. FMR LLC lifted its holdings in UnitedHealth Group by 2.0% in the 2nd quarter. FMR LLC now owns 49,813,470 shares of the healthcare conglomerate’s stock valued at $25,585,693,000 after purchasing an additional 998,214 shares in the last quarter. State Street Corp lifted its holdings in UnitedHealth Group by 1.6% in the 1st quarter. State Street Corp now owns 46,274,771 shares of the healthcare conglomerate’s stock valued at $23,598,745,000 after purchasing an additional 714,903 shares in the last quarter. Capital World Investors lifted its holdings in UnitedHealth Group by 2.8% in the 1st quarter. Capital World Investors now owns 34,805,861 shares of the healthcare conglomerate’s stock valued at $17,750,351,000 after purchasing an additional 935,552 shares in the last quarter. Finally, Capital Research Global Investors lifted its holdings in UnitedHealth Group by 8.3% in the 1st quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after purchasing an additional 1,482,338 shares in the last quarter. 87.25% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Up 1.3 %
Shares of UnitedHealth Group stock traded up $6.62 on Thursday, hitting $529.71. 2,238,349 shares of the company’s stock traded hands, compared to its average volume of 3,418,937. The stock has a market cap of $494.93 billion, a P/E ratio of 25.94, a PEG ratio of 1.63 and a beta of 0.75. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.58. The firm’s 50-day moving average is $524.05 and its 200 day moving average is $515.70. UnitedHealth Group Incorporated has a 52-week low of $438.21 and a 52-week high of $558.10.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Monday, December 5th will be paid a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date of this dividend is Friday, December 2nd. UnitedHealth Group’s payout ratio is 32.32%.
Analyst Ratings Changes
UNH has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $569.00 to $615.00 and gave the stock a “buy” rating in a report on Tuesday, October 18th. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price objective on the stock. in a report on Monday. StockNews.com started coverage on shares of UnitedHealth Group in a report on Wednesday, October 12th. They set a “strong-buy” rating on the stock. Credit Suisse Group increased their target price on shares of UnitedHealth Group from $579.00 to $590.00 and gave the stock an “outperform” rating in a research report on Monday, October 17th. Finally, Royal Bank of Canada increased their target price on shares of UnitedHealth Group from $588.00 to $592.00 and gave the stock an “outperform” rating in a research report on Monday, October 17th. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $595.11.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.40% of the stock is currently owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Is the 60/40 Portfolio Mix Still in Vogue?
- Institutional Support for Analog Devices Remains High
- Three CBD Stocks to Dominate a Budding Industry
- Microsoft Shares: Is it Time to Back Up the Truck?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.